We are live on
!
Find out more
NHC
Nicholas Hoffman & Company Portfolio holdings
AUM
$4.74B
1-Year Est. Return
18.12%
This Fund
S&P 500
This Quarter
Est. Return
+6.31%
1 Year Est. Return
+18.12%
3 Year Est. Return
+65.12%
5 Year Est. Return
+53.27%
10 Year Est. Return
+210.2%
AUM
$255M
AUM Growth
+$17.4M
(+7.3%)
Cap. Flow
+$3.23M
Cap. Flow
% of AUM
1.27%
Top 10 Holdings %
Top 10 Hldgs %
40.98%
Holding
173
New
9
Increased
70
Reduced
65
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.37M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$874K |
| 3 |
SLB Ltd
SLB
|
+$547K |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$522K |
| 5 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$518K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$639K |
| 2 |
Chevron
CVX
|
+$538K |
| 3 |
GSK
GSK
|
+$425K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$359K |
| 5 |
TSMC
TSM
|
+$339K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 12% |
| 2 | Technology | 10.83% |
| 3 | Financials | 9.85% |
| 4 | Healthcare | 7.55% |
| 5 | Consumer Discretionary | 4.39% |
Similar funds
SAMU
JCM
VDI
KCM
RC
GCL
AA
Nicholas Hoffman & Company's Q4 2017 Portfolio in Review
As of Q4 2017, Nicholas Hoffman & Company held 173 positions worth $255M, up 7.3% from $237M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Nicholas Hoffman & Company's Q4 2017 filing shows 9 new, 70 increased, 65 reduced and 7 closed positions. Its largest new stake was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K. The largest sale was Walmart Inc, an estimated $639K.
By sector, the portfolio is most concentrated in Consumer Staples at 12% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
- Nicholas Hoffman & Company's largest Q4 2017 buy was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K.
- Nicholas Hoffman & Company added most to Vanguard S&P 500 ETF in Q4 2017, an estimated $2.37M increase.
- Nicholas Hoffman & Company's biggest Q4 2017 reduction was Walmart Inc, cutting an estimated $639K.
- Nicholas Hoffman & Company fully exited Celgene Corp in Q4 2017, selling an estimated $260K.
- Nicholas Hoffman & Company's ten largest holdings make up 41% of its $255M portfolio in Q4 2017.
- Nicholas Hoffman & Company opened 9 new positions and closed 7 in Q4 2017.
- Nicholas Hoffman & Company's portfolio value rose 7.3% quarter-over-quarter to $255M.
Based on Nicholas Hoffman & Company's 13F filing for Q4 2017, filed 9 Feb 2018.